1.49

2.76% 0.04

After Hours: 1.49

Adc Therapeutics Sa (ADCT)

Overview News Price History Option Chain Financials Discussions Forecast Stock Split

Adc Therapeutics Sa stock is traded at $1.49, with a volume of 1.33M. It is up +2.76% in the last 24 hours and up +36.70% over the past month. ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company's FDA-approved and marketed product, ZYNLONTA (loncastuximab tesirine), is a CD19-directed antibody and alkylating agent conjugate indicated for the treatment of adult patients with relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy. Additionally, the company's development pipeline comprises LOTIS-2, LOTIS-5, LOTIS-7, and ADCT-241, being developed as potential therapies for different cancer diseases. Geographically, the firm generates maximum revenue from the United States, followed by Europe, the Middle East and Africa (EMEA).

Previous Close:

$1.45

Open:

$1.47

24h Volume:

1.33M

Relative Volume:

0.58

Market Cap:

$190.22M

Revenue:

$79.18M

Net Income/Loss:

$-136.99M

P/E Ratio:

-1.4127

EPS:

-1.0547

Net Cash Flow:

$-120.11M

1W Performance:

-6.29%

1M Performance:

+36.70%

6M Performance:

-65.90%

1Y Performance:

-65.02%

1-Day Range:

$1.46

$1.565

1-Week Range:

$1.40

$1.87

52-Week Range:

$0.7796

$4.98

Adc Therapeutics Sa Stock (ADCT) Company Profile

Name

Adc Therapeutics Sa

Sector

Healthcare (1051)

Industry

Drug Manufacturers - Specialty & Generic (84)

Phone

41 21 653 02 00

Address

BIOPOLE, EPALINGES

Employee

193

Twitter

Next Earnings Date

2026-11-09

Latest SEC Filings

ADCT's Discussions on Twitter

Compare ADCT vs TAK, TEVA, HLN, ZTS, UTHR

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
ADCT Adc Therapeutics Sa	1.49	190.22M	79.18M	-136.99M	-120.11M	-1.0547
TAK Takeda Pharmaceutical Co Adr	19.45	62.13B	29.91B	1.30B	3.49B	0.4056
TEVA Teva Pharmaceutical Industries Ltd Adr	41.11	47.95B	17.53B	1.58B	444.18M	1.3457
HLN Haleon Plc Adr	9.94	43.71B	14.54B	2.22B	2.58B	0.4871
ZTS Zoetis Inc	78.42	32.40B	9.51B	2.64B	2.14B	6.0361
UTHR United Therapeutics Corp	541.51	23.23B	3.17B	1.29B	1.01B	27.09

Adc Therapeutics Sa Stock (ADCT) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jun-08-26	Downgrade	H.C. Wainwright	Buy → Neutral
Jun-04-26	Downgrade	RBC Capital Mkts	Outperform → Sector Perform
Nov-08-24	Initiated	Stephens	Overweight
May-30-24	Initiated	Cantor Fitzgerald	Overweight
Mar-28-24	Initiated	Guggenheim	Buy
Aug-10-23	Upgrade	JP Morgan	Underweight → Neutral
Apr-24-23	Downgrade	BofA Securities	Neutral → Underperform
Dec-06-22	Initiated	CapitalOne	Overweight
Nov-09-22	Downgrade	BofA Securities	Buy → Neutral
Sep-21-22	Initiated	JP Morgan	Overweight
Sep-09-22	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Nov-09-21	Initiated	Wolfe Research	Outperform
Aug-17-21	Resumed	Jefferies	Buy
Aug-09-21	Initiated	RBC Capital Mkts	Outperform
Jun-15-21	Initiated	Cantor Fitzgerald	Overweight
Dec-03-20	Initiated	Stifel	Hold
Oct-29-20	Initiated	H.C. Wainwright	Buy
Jun-09-20	Initiated	BofA/Merrill	Buy
Jun-09-20	Initiated	Cowen	Outperform

View All

Adc Therapeutics Sa Stock (ADCT) Latest News

Sep 12, 2026